Skip to main content

Table 5 Variance decomposition

From: Economic and non-economic determinants of Iranian pharmaceutical companies’ financial performance: an empirical study

HE

VOSOL

R

M1

INFD

GDPH

EX

TEP

S.E.

Period

0.000000

0.000000

0.000000

0.000000

0.000000

0.000000

0.000000

100.0000

0.111224

1

(0.00000)

(0.00000)

(0.00000)

(0.00000)

(0.00000)

(0.00000)

(0.00000)

(0.00000)

0.643716

0.516556

3.645996

4.275571

3.045998

6.745288

6.498856

74.62802

0.135257

2

(1.58969)

(2.47750)

(4.14222)

(4.38718)

(4.44909)

(5.81670)

(5.83215)

(10.0833)

1.885852

0.552555

3.125592

8.092319

5.987067

6.270742

7.027835

67.05804

0.147539

3

(2.29192)

(3.23537)

(3.69456)

(5.87893)

(5.47160)

(5.30892)

(5.48121)

(9.82294)

3.113979

0.882011

3.254085

9.538053

6.176203

6.241883

7.927058

62.86673

0.152701

4

(2.96393)

(3.82667)

(4.22017)

(6.31393)

(5.72438)

(5.21573)

(5.63885)

(9.78998)

3.665863

0.871941

3.813322

9.110137

5.895478

5.909447

11.21041

59.52340

0.156943

5

(3.07758)

(4.05572)

(5.02856)

(5.73867)

(5.56695)

(5.02425)

(6.75392)

(9.59936)

4.106707

1.026344

4.940055

8.804775

5.910681

5.702113

11.58808

57.92125

0.159773

6

(3.20950)

(4.29927)

(6.30071)

(5.47682)

(5.55962)

(5.04474)

(6.64298)

(9.35905)

4.479130

1.531116

6.063675

8.625048

5.797920

5.590064

11.31098

56.60207

0.162475

7

(3.27950)

(4.62186)

(7.17887)

(5.28394)

(5.59362)

(5.07553)

(6.49288)

(9.31475)

4.354149

1.801515

5.850278

8.378294

7.041856

5.346722

11.37644

55.85075

0.166133

8

(3.25200)

(4.89775)

(7.53143)

(5.21896)

(5.93316)

(5.02693)

(6.50874)

(9.28173)

4.307578

2.112254

6.193077

9.156914

7.479709

5.158353

11.29346

54.29866

0.169156

9

(3.15717)

(5.15227)

(7.45971)

(5.36344)

(6.27615)

(5.00786)

(6.60511)

(9.20960)

4.266167

2.729970

6.877257

9.182257

7.560340

5.051597

10.99235

53.34006

0.171478

10

(3.12107)

(5.34217)

(7.70037)

(5.34699)

(6.44625)

(4.98286)

(6.52365)

(9.24829)